FDA approves AndexXa, first antidote for the reversal of factor Xa inhibitors

FDA approves AndexXa, first antidote for the reversal of factor Xa inhibitors  The Pharma Letter Andexxa Approved for Reversal of Factor Xa Inhibitors  Rare Disease Report FDA Approves Portola Pharmaceuticals' Andexxa  Pharmaceutical ProcessingFull coverage